Literature DB >> 22306736

Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line.

Daniel C Lazar1, Edward H Cho, Madelyn S Luttgen, Thomas J Metzner, Maria Loressa Uson, Melissa Torrey, Mitchell E Gross, Peter Kuhn.   

Abstract

Many important experiments in cancer resen class="Gene">arch are initiated with cell line data analysis due to the ease of accessibility and utilization. Recently, the ability to capture and characterize circulating tumor cells (CTCs) has become more prevalent in the research setting. This ability to detect, isolate and analyze CTCs allows us to directly compare specific protein expression levels found in patient CTCs to cell lines. In this study, we use immunocytochemistry to compare the protein expression levels of total cytokeratin (CK) and androgen receptor (AR) in CTCs and cell lines from patients with prostate cancer to determine what translational insights might be gained through the use of cell line data. A non-enrichment CTC detection assay enables us to compare cytometric features and relative expression levels of CK and AR by indirect immunofluorescence from prostate cancer patients against the prostate cancer cell line LNCaP. We measured physical characteristics of these two groups and observed significant differences in cell size, fluorescence intensity and nuclear to cytoplasmic ratio. We hope that these experiments will initiate a foundation to allow cell line data to be compared against characteristics of primary cells from patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306736      PMCID: PMC3387997          DOI: 10.1088/1478-3975/9/1/016002

Source DB:  PubMed          Journal:  Phys Biol        ISSN: 1478-3967            Impact factor:   2.583


  19 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Portable filter-based microdevice for detection and characterization of circulating tumor cells.

Authors:  Henry K Lin; Siyang Zheng; Anthony J Williams; Marija Balic; Susan Groshen; Howard I Scher; Martin Fleisher; Walter Stadler; Ram H Datar; Yu-Chong Tai; Richard J Cote
Journal:  Clin Cancer Res       Date:  2010-09-28       Impact factor: 12.531

3.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip.

Authors:  Shannon L Stott; Chia-Hsien Hsu; Dina I Tsukrov; Min Yu; David T Miyamoto; Belinda A Waltman; S Michael Rothenberg; Ajay M Shah; Malgorzata E Smas; George K Korir; Frederick P Floyd; Anna J Gilman; Jenna B Lord; Daniel Winokur; Simeon Springer; Daniel Irimia; Sunitha Nagrath; Lecia V Sequist; Richard J Lee; Kurt J Isselbacher; Shyamala Maheswaran; Daniel A Haber; Mehmet Toner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-07       Impact factor: 11.205

Review 4.  Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

Authors:  R E Sobel; M D Sadar
Journal:  J Urol       Date:  2005-02       Impact factor: 7.450

5.  A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter.

Authors:  Tong Xu; Bo Lu; Yu-Chong Tai; Amir Goldkorn
Journal:  Cancer Res       Date:  2010-07-27       Impact factor: 12.701

6.  Cytomorphology of circulating colorectal tumor cells:a small case series.

Authors:  Dena Marrinucci; Kelly Bethel; Daniel Lazar; Jennifer Fisher; Edward Huynh; Peter Clark; Richard Bruce; Jorge Nieva; Peter Kuhn
Journal:  J Oncol       Date:  2010-01-06       Impact factor: 4.375

7.  Comparative Membranome expression analysis in primary tumors and derived cell lines.

Authors:  Paolo Uva; Armin Lahm; Andrea Sbardellati; Anita Grigoriadis; Andrew Tutt; Emanuele de Rinaldis
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

8.  Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin.

Authors:  Zhaoxu Liu; Marcela Marquez; Sten Nilsson; Anders R Holmberg
Journal:  Oncol Rep       Date:  2009-12       Impact factor: 3.906

Review 9.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

Review 10.  Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?

Authors:  Maximilian Bockhorn; Rakesh K Jain; Lance L Munn
Journal:  Lancet Oncol       Date:  2007-05       Impact factor: 41.316

View more
  26 in total

1.  Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer.

Authors:  Anders Carlsson; Viswam S Nair; Madelyn S Luttgen; Khun Visith Keu; George Horng; Minal Vasanawala; Anand Kolatkar; Mehran Jamali; Andrei H Iagaru; Ware Kuschner; Billy W Loo; Joseph B Shrager; Kelly Bethel; Carl K Hoh; Lyudmila Bazhenova; Jorge Nieva; Peter Kuhn; Sanjiv S Gambhir
Journal:  J Thorac Oncol       Date:  2014-08       Impact factor: 15.609

2.  Using circulating tumor cells to advance precision medicine in prostate cancer.

Authors:  Giuseppe Galletti; Daniel Worroll; David M Nanus; Paraskevi Giannakakou
Journal:  J Cancer Metastasis Treat       Date:  2017-09-27

3.  Circulating Tumor Cells: When a Solid Tumor Meets a Fluid Microenvironment.

Authors:  Katarzyna A Rejniak
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

4.  Circulating tumor cells as emerging tumor biomarkers in lung cancer.

Authors:  Edward H Cho
Journal:  J Thorac Dis       Date:  2012-10       Impact factor: 2.895

Review 5.  Circulating tumour cells-monitoring treatment response in prostate cancer.

Authors:  David T Miyamoto; Lecia V Sequist; Richard J Lee
Journal:  Nat Rev Clin Oncol       Date:  2014-05-13       Impact factor: 66.675

Review 6.  Using circulating tumor cells to inform on prostate cancer biology and clinical utility.

Authors:  Jing Li; Simon G Gregory; Mariano A Garcia-Blanco; Andrew J Armstrong
Journal:  Crit Rev Clin Lab Sci       Date:  2015-06-16       Impact factor: 6.250

7.  Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay.

Authors:  Wael Harb; Andrea Fan; Tony Tran; Daniel C Danila; David Keys; Michael Schwartz; Cristian Ionescu-Zanetti
Journal:  Transl Oncol       Date:  2013-10-01       Impact factor: 4.243

Review 8.  Fluid biopsy for solid tumors: a patient's companion for lifelong characterization of their disease.

Authors:  Jorge J Nieva; Peter Kuhn
Journal:  Future Oncol       Date:  2012-08       Impact factor: 3.404

9.  Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.

Authors:  Giuseppe Galletti; Luigi Portella; Scott T Tagawa; Brian J Kirby; Paraskevi Giannakakou; David M Nanus
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

Review 10.  Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA.

Authors:  Daniel A Haber; Victor E Velculescu
Journal:  Cancer Discov       Date:  2014-05-06       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.